Revenue | ₹709.70Cr |
Net Profits | ₹104.56Cr |
Net Profit Margins | 14.73% |
Marksans Pharma Ltd’s revenue jumped 20.1% since last year same period to ₹709.70Cr in the Q3 2024-2025. On a quarterly growth basis, Marksans Pharma Ltd has generated 8.69% jump in its revenue since last 3-months.
Marksans Pharma Ltd’s net profit jumped 25.61% since last year same period to ₹104.56Cr in the Q3 2024-2025. On a quarterly growth basis, Marksans Pharma Ltd has generated 8.11% jump in its net profits since last 3-months.
Marksans Pharma Ltd’s net profit margin jumped 4.59% since last year same period to 14.73% in the Q3 2024-2025. On a quarterly growth basis, Marksans Pharma Ltd has generated -0.53% fall in its net profit margins since last 3-months.
The revenue for Marksans Pharma Ltd in the Q3 results 2024 was ₹709.70Cr.
The net profit for Marksans Pharma Ltd in the Q3 results 2024 was ₹104.56Cr.
The net profit margin for Marksans Pharma Ltd in the Q3 results 2024 was 14.73%.
The revenue for Marksans Pharma Ltd in the Q3 results 2023 was ₹590.93Cr.
The net profit for Marksans Pharma Ltd in the Q3 results 2023 was ₹83.24Cr.
The net profit margin for Marksans Pharma Ltd in the Q3 results 2023 was 14.09%.